Pricing Log in Create free account

Bone Biologics Corp. (BBLG) vs Curis, Inc. (CRIS)

Bone Biologics Corp. and Curis, Inc. are both Biotechnology companies. Bone Biologics Corp. and Curis, Inc. are of similar size ($1.1M and $1.1M). Across the 8 metrics below, Bone Biologics Corp. leads on 5 and Curis, Inc. on 3.

Valuation

Metric BBLG CRIS Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.09 9.71
P/B 0.18 0.19 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.41 0.64
EV/Sales n/m (0.37) 9.21
Earnings yield (342.50%) (3,468.29%) (33.15%)
Free cash flow yield (365.78%) (3,540.29%) (25.50%)

Profitability

Metric BBLG CRIS Biotechnology median
Gross margin — 99.52% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (54.96%) 455.35% (56.36%)
Return on assets (50.55%) (87.76%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BBLG CRIS Biotechnology median
Revenue growth (TTM) — (13.43%) 6.02%
EPS growth (last fiscal year) 90.85% 91.57% 30.26%
Revenue growth, 5-year CAGR — (2.71%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BBLG CRIS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.67 0.49 4.72
Net debt to EBITDA 1.65 0.91 0.96

Dividend

Metric BBLG CRIS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BBLG CRIS Biotechnology median
Market cap 1.07m 1.06m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack